Bausch Health Companies Inc has seen significant price movement this week, driven by positive earnings news.
Bausch Health Companies Inc (BHC.TO) has experienced a remarkable week, with shares surging approximately 54.40% over the past week. The stock closed at C$9.65 on Monday, reflecting a substantial gain of 14.47% in just one day. This movement comes on the heels of the company’s recent second-quarter earnings report, which showcased better-than-expected results and an optimistic outlook.
Investor takeaway: The recent earnings report from Bausch Health has instilled renewed confidence in investors, leading to a sharp rise in stock price. However, with a bearish outlook from analysts, investors should proceed with caution.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.61B
52W high
$11.97
52W low
$6.10
1W change
+54.40%
Beta
0.42
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 27.4% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-27.4% Upside
Current Price
C$9.65
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
93.6%
Annualized
90-Day Vol
63.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$11.54
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.24 | C$7.41 – C$14.15 |
| 60 trading days | C$10.87 | C$6.88 – C$17.16 |
| 90 trading days | C$11.54 | C$6.59 – C$20.19 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bausch Health Shares Surge 54.40% This Week
The stock's recent performance reflects a strong market reaction to its earnings report, but analysts suggest caution with a bearish outlook.
Bull case
Bausch Health's strong Q2 performance, driven by growth in its Salix and Solta divisions, shows its potential for recovery and could attract further investor interest.
Bear case
Despite the positive earnings report, analysts remain cautious, with an average target price significantly below the current trading price, indicating potential volatility ahead.
Price Action
Bausch Health Companies Inc (BHC.TO) closed at C$9.65 on Monday, reflecting a significant one-day increase of 14.47%. Over the past week, the stock has surged by 54.40%, indicating strong investor interest following its earnings announcement.
Advertisement
Company News
The dramatic rise in Bausch Health's stock can be attributed to the release of its second-quarter earnings report. The company reported a notable turnaround, with earnings and revenues exceeding analyst expectations. Key factors contributing to this positive performance included growth in its Salix and Solta divisions, prompting the company to raise its guidance for the upcoming fiscal year.
Technical Picture
Bausch Health's stock is currently trading well above its 50-day moving average of C$7.03, indicating a bullish trend. The stock's 200-day moving average stands at C$8.09, also reflecting a favorable position compared to the current price. The 52-week range for BHC.TO has been C$6.10 to C$11.97, with the stock now trading at approximately 60% of its 52-week range. The beta of 0.42 suggests that the stock is less volatile than the broader market, which may appeal to more conservative investors.
Insider Activity
No recent insider activity has been reported for Bausch Health Companies Inc.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
